Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Abiomed Inc (NASDAQ:ABMD)

100.37
Delayed Data
As of Jun 24
 -3.88 / -3.72%
Today’s Change
64.03
Today|||52-Week Range
110.68
+11.18%
Year-to-Date
SECTOR
Health Technology
INDUSTRY
Medical Specialties
MARKET CAP
$4.3B

Company Description

ABIOMED, Inc. engages in the research, development, manufacture, and sale of cardiac support, recovery, and replacement devices. It distributes its products under the Impella brand. The company was founded in 1981 and is headquartered in Danvers, MA.

Contact Information

ABIOMED, Inc.
22 Cherry Hill Drive
Danvers Massachusetts 01923
P:(978) 646-1400
Investor Relations:
(978) 676-1590

Employees

Shareholders

Mutual fund holders56.03%
Other institutional37.15%
Individual stakeholders18.07%

Top Executives

Michael R. MinogueChairman, President & Chief Executive Officer
David M. WeberChief Operating Officer
Michael John TomsicekChief Financial Officer & Vice President
Karim BenaliChief Medical Officer
Thorsten SiessChief Technology Officer